iiinova — where your digital self keeps evolving

Daniel Aletaha @danielaletaha.bsky.social · 05/10/2026

Very pleased to share our new review on #RheumatoidArthritis, now published in JAMA. We review current evidence on RA pathogenesis, diagnosis, assessment & treatment, and its implications for clinical practice >> doi.org/10.1001/jama...

doi.org

Rheumatoid Arthritis in Adults: A Review

This Review discusses the pathogenesis, epidemiology, risk factors, clinical presentation, diagnosis, treatment, and prognosis of rheumatoid arthritis (RA).

000

Daniel Aletaha @danielaletaha.bsky.social · 10/09/2026

Congratulations to all the authors and collaborators, and many thanks to everyone involved in these studies!

010

Daniel Aletaha @danielaletaha.bsky.social · 10/09/2026

Difficult-to-treat RA: an updated review of treatment strategies for difficult-to-treat RA, including the evidence around JAK inhibitors after multiple treatment failures and the importance of individual risk assessment, within the frame of @strata-fit.bsky.social. doi.org/10.1136/rmdo...

doi.org

Therapeutic approaches for difficult-to-treat rheumatoid arthritis: a systematic literature review of current evidence

Objective This systematic literature review (SLR) aims to update the evidence regarding therapeutic strategies in difficult-to-treat rheumatoid arthritis (D2T RA), building on the previous SLR informi...

100

Daniel Aletaha @danielaletaha.bsky.social · 10/09/2026

Ultrasound scoring of joint damage in RA: the new GLODS system provides a standardized approach to assessing structural joint damage by ultrasound, developed through the OMERACT process. doi.org/10.1016/j.ar...

doi.org

Redirecting

100

Daniel Aletaha @danielaletaha.bsky.social · 10/09/2026

Sjögren disease-associated ILD: a European multicentre cohort looking at treatment patterns, disease progression and survival in SjD-ILD, highlighting some of the challenges that remain in managing these patients. doi.org/10.1016/j.ja...

doi.org

Redirecting

100

Daniel Aletaha @danielaletaha.bsky.social · 10/09/2026

Ultrasound and treatment withdrawal in RA: the RA-BioStop study explored whether ultrasound findings could help predict relapse after stopping bDMARDs in patients in remission. While the study was stopped early, the results provide interesting directions for future work. doi.org/10.1136/rmdo...

doi.org

Ultrasound-based withdrawal of biologics in rheumatoid arthritis (RA-BioStop)

Objective To test whether ultrasonography of patients with rheumatoid arthritis (RA) in the American College of Rheumatology/the European Alliance of Associations for Rheumatology (ACR/EULAR) remissio...

100

Daniel Aletaha @danielaletaha.bsky.social · 10/09/2026

TTV as a biomarker in RA: we looked at how reproducible TTV DNA measurements are when using smaller serum volumes, an important practical aspect for biobanking and larger studies. This work is embedded within our @squeezeproject.bsky.social consortium. doi.org/10.3390/meds...

doi.org

110

Daniel Aletaha @danielaletaha.bsky.social · 10/09/2026

Last month was particularly busy for our Division’s research, with a broad range of studies published across rheumatology and related fields. In case you missed them, here’s a recap, from biomarkers and ultrasound in rheumatoid arthritis to Sjögren disease, vaccination, and D2T RA:

111

Reposted by Daniel Aletaha

MedUni Wien @meduniwien.ac.at · 30/07/2026

💊 #Methotrexate has been the mainstay of treatment for #RheumatoidArthritis. Researchers at #MedUniVienna analysed how the drug alters the #immunesystem during the first few weeks of treatment. ⬇️ 💡 MTX triggers coordinated changes in the immune system within just a few weeks. 📰 @ard.eular.org

meduniwien.ac.at

Rheumatoid arthritis: Early immune changes during methotrexate treatment may predict treatment success

Details of the MedUni Vienna study!

083

Daniel Aletaha @danielaletaha.bsky.social · 15/06/2026

What a fantastic #EULAR2026 in London! Proud of the outstanding scientific contributions from our Division of Rheumatology @meduniwien.ac.at, from talks, posters and chairing to leadership in key sessions. Great visibility also for @squeezeproject.bsky.social and @autopix.bsky.social!

051

Reposted by Daniel Aletaha

SQUEEZE project @squeezeproject.bsky.social · 04/06/2026

Did you notice the large crowd of people in the NPO area last night just before the networking dinner at #EULAR2026? There's heaps of passionate clinicians, scientists, HCP, & patients involved in a large number of EU consortia like SQUEEZE - come by at booth **O17** and learn more about our work!

094

Reposted by Daniel Aletaha

SQUEEZE project @squeezeproject.bsky.social · 05/06/2026

Please help us by completing this survey on the availability, accessibility & affordability of #RA treatments across Europe. The results will help identify disparities in the treatment access across Europe & support future evidence-based recommendations for more equitable care. #EULAR2026

066

Reposted by Daniel Aletaha

The European Alliance of Associations for Rheumatology @eular.org · 03/06/2026

✨ Join us at 1pm BST via livestream or in person as we officially kick off #EULAR2026! Led by the EULAR Board, the Opening Plenary brings together the community to highlight key Congress moments and honour excellence in RMDs through the Award Ceremony. Watch here 👉 pulse.ly/g91er5akam

161

Daniel Aletaha @danielaletaha.bsky.social · 03/06/2026

Safety is key in RA management! The 2025 @eular.org update, led by Faidra Laskou & Victoria Konzett, reviews DMARD risks from infections to cardiovascular events. How does this shape practice? Read more: doi.org/10.1016/j.ar.... Grateful to global collaborators for advancing RA care!

doi.org

Redirecting

010

Daniel Aletaha @danielaletaha.bsky.social · 07/05/2026

4th virtual @squeezeproject.bsky.social consortium meeting done. A moment to reflect on 3.5 years of work improving RA care and align on the road to Nov next year. Thanks to all of our partners!

031

Reposted by Daniel Aletaha

MedUni Wien @meduniwien.ac.at · 07/04/2026

Can biomarkers and personalised care end years of trial and error for people with #rheumatoidarthritis? The EU-funded SQUEEZE project, coordinated by @danielaletaha.bsky.social from #MedUniVienna aims to optimise existing therapies and bring more patients into remission. ⬇️ #Rheumatology

projects.research-and-innovation.ec.europa.eu

Find out more!

162

Daniel Aletaha @danielaletaha.bsky.social · 24/03/2026

Peter Mandl reframes the synovium as a “synovial interface” where biology, imaging & patient perception intersect. His new perspective (doi.org/10.1016/j.aa...) challenges us to rethink how we assess inflammation beyond single measures and toward integrated monitoring. Congrats, Peter!

doi.org

Redirecting

000

Daniel Aletaha @danielaletaha.bsky.social · 16/03/2026

Thirty years go by quickly. Building something that lasts does not. We recently celebrated 30 years of university rheumatology in Austria. From history to AI, imaging and patient partnership, one thing is clear: the discipline is not standing still! @squeezeproject.bsky.social @autopix.bsky.social

130

Daniel Aletaha @danielaletaha.bsky.social · 19/11/2025

Today, on #MensHealthDay, let’s raise awareness of men-biased autoimmune diseases like axial spondylarthritis, and women-biased autoimmune disease in men! www.internationalmensday.info

internationalmensday.info

International Mens Day

International Men’s Day (IMD) is celebrated on 19 November every year and is marked in around 80 countries worldwide.

000

Daniel Aletaha @danielaletaha.bsky.social · 28/10/2025

Helga Lechner-Radner joined ORF’s Bewusst gesund to discuss “Leben mit Rheuma”. She highlighted that rheumatic diseases go far beyond joint pain, early diagnosis and modern therapy can truly change lives. 🎥 onepager.orf.at/bewusstgesun...

onepager.orf.at

Studiogespräch: Leben mit Rheuma

000

Daniel Aletaha @danielaletaha.bsky.social · 09/10/2025

I recently shared my thoughts on Austria’s strong global role in rheumatology in my recent Schmerz Nachrichten interview, from @eular.org initiatives to digital innovation and equity in care. Grateful to all who make this collaboration possible. 🇦🇹 link.springer.com/article/10.1...

link.springer.com

Österreichs starker Footprint in der globalen Rheuma-Community - Schmerz Nachrichten

Schmerz Nachrichten -

020

Daniel Aletaha @danielaletaha.bsky.social · 19/09/2025

At the Dresden Symposium on Autoantibodies 2025, Daniela Sieghart presented on biomarkers for RA treatment response, highlighting EU projects @squeezeproject.bsky.social & @autopix.bsky.social. Our division drives precision medicine forward, tailoring care through innovative biomarkers.

074

Daniel Aletaha @danielaletaha.bsky.social · 16/09/2025

New in Journal of Autoimmunity: our study on FAPI PET/CT in myositis-related ILD, led by Kastriot Kastrati & Peter Mandl. Findings show FAPI uptake predicts progression better than standard tools, promising step for personalized care. 📖 doi.org/10.1016/j.ja...

doi.org

Redirecting

000

Reposted by Daniel Aletaha

AutoPiX project @autopix.bsky.social · 09/09/2025

🚀 Meet our supportive partner: @inmusc.bsky.social #InMusc is a Spanish consultancy that helps transform ideas into impact through research and #methodology training. Their mission is to make research collaborations agile, relevant, and meaningful.

172

Daniel Aletaha @danielaletaha.bsky.social · 08/09/2025

📢 New from our Division of Rheumatology: Peter Mandl on the expanding role of ultrasound in rheumatology - beyond joints to glands, vessels, lungs & muscles. Real-time, radiation-free imaging for diagnosis & management. 🎥 www.youtube.com/watch?v=XgOO...

000

Daniel Aletaha @danielaletaha.bsky.social · 01/09/2025

Our study on how global recruitment patterns affect placebo response in RA trials has gained broad Austrian media coverage (ORF, NÖN, SN & more). Great to see interest in how trial design impacts fair evaluation of new therapies! 🔗 science.orf.at/stories/3231...

science.orf.at

Stärkerer Placeboeffekt bei Ärmeren

Der Placeboeffekt und die sozioökonomische Lebensrealität hängen laut Untersuchungen der Wiener MedUni zusammen. In Studien aus ärmeren Ländern reagieren die Probanden und Probandinnen stärker auf das...

000

Daniel Aletaha @danielaletaha.bsky.social · 25/08/2025

Two new papers from our division show that recruiting RA & PsA trial patients in less affluent regions increase placebo rates - likely from limited treatment access. Trial design must adapt. RA: doi.org/10.1016/j.ar... PsA: doi.org/10.1002/art....

doi.org

Redirecting

000

Reposted by Daniel Aletaha

The European Alliance of Associations for Rheumatology @eular.org · 21/08/2025

Join the 9th EULAR Course on Immunology 2026, a highly interactive course focused on key immunology concepts and practical research project design. 📅 6-7 February 2026 📍Amsterdam, Netherlands 🔔Registration deadline: 2 November 2025 Register here: pulse.ly/nul3x4sazs #eularEDUCATION

021

Reposted by Daniel Aletaha

European Medical Journal @emjreviews.com · 18/08/2025

‪Discover more of @danielaletaha.bsky.social‬, @meduniwien.ac.at and past ‪@eular.org‬ president's thoughts on EMJ: www.emjreviews.com/rheumatology...

011

Reposted by Daniel Aletaha

The European Alliance of Associations for Rheumatology @eular.org · 12/08/2025

Join the 8th EULAR Imaging Course 2026, an intensive, hands-on course covering key imaging techniques in rheumatology, from X-ray to MRI and ultrasound. 📅5-6 February 2026 📍Amsterdam, Netherlands 🔔Registration deadline: 2 November 2025 Register here: pulse.ly/5a9ni8gnzs #eularEDUCATION

011

Reposted by Daniel Aletaha

The European Alliance of Associations for Rheumatology @eular.org · 01/08/2025

📸 Behind every project is a team. During the EULAR 2025 Congress in Barcelona, we had the pleasure to meet with members of six research consortia: HIPPOCRATES, SQUEEZE, STRATA-FIT, MDR-RA, PerPrev-CID, and AutoPiX. 👉 Interested in partnering with us? Learn more here: pulse.ly/58wj8jwuui

082

Reposted by Daniel Aletaha

The European Alliance of Associations for Rheumatology @eular.org · 06/08/2025

🚀Join us on our #EULAR and #EMEUNET Webinar: "Gender-specific differences in rheumatic diseases" 💻Wednesday, 13 Aug 2025, 18:00-18:45 CEST Register here👉https://pulse.ly/lqp4vkeeod #eularEMEUNET #Rheumatology

041

Daniel Aletaha @danielaletaha.bsky.social · 07/08/2025

Can women with systemic autoimmune rheumatic diseases pass on robust immunity to their babies? Turns out - yes. 👶🛡️ Proud to share our latest collaborative study on maternal antibody transfer in the Journal of Autoimmunity: doi.org/10.1016/j.ja...

doi.org

Redirecting

020

Daniel Aletaha @danielaletaha.bsky.social · 01/08/2025

At KinderUni 2025, our division of Rheumatology @meduniwien.ac.at explored the fascinating world of autoimmunity with Vienna’s youngest scientists. Huge thanks to our amazing team for inspiring future researchers! 👉 kinderuni-anmeldung.at/event.php?ev...

040

Reposted by Daniel Aletaha

MedUni Wien @meduniwien.ac.at · 10/07/2025

Idiopathic #inflammatorymyopathies are rare #autoimmunediseases in which the #immunesystem attacks the body's own #musclecells. A team from #MedUniVienna has systematically described the safety and efficacy of targeted #immunotherapy in refractory idiopathic inflammatory #myopathies. ⬇️

meduniwien.ac.at

New treatment option investigated for difficult-to-treat muscle inflammation

Details on the results of the retrospective observational study!

143

Daniel Aletaha @danielaletaha.bsky.social · 30/06/2025

Great meeting in Stockholm with the @autopix.bsky.social team! Thanks @collectiveminds.bsky.social for hosting. We're advancing AI tools to improve rheumatic care - excited for what’s ahead!

020

Daniel Aletaha @danielaletaha.bsky.social · 26/06/2025

Check out the interview I made within the frame of #EULAR2025 with the talented EMEUNET Newsletter Sub-Committee members Anastasia Madenidou and Victoria Konzett 👇 emeunews.org/2025/06/01/t...

010

Daniel Aletaha @danielaletaha.bsky.social · 13/06/2025

Check out my interview, masterfully led by Valentina Pucino after the plenary session of #EULAR2025 👇 www.youtube.com/watch?v=d6hi...

youtube.com

EULAR 2025 - Interview with Prof. Daniel Aletaha

YouTube video by EULAR

083

Daniel Aletaha @danielaletaha.bsky.social · 12/06/2025

Proud to showcase the @squeezeproject.bsky.social at #EULAR2025! Visit booth O9 (near Hall 8.1, NPO area) to learn how we’re advancing precision medicine in RA to get the right treatment to the right patient.

030

Daniel Aletaha @danielaletaha.bsky.social · 12/06/2025

Proud of our @autopix.bsky.social at #EULAR2025! Visit us at booth O8 (near Hall 8.1, NPO area) to learn how we’re using AI to advance rheumatic image analysis for better patient care.

050

Reposted by Daniel Aletaha

Lupus Europe @lupuseurope.bsky.social · 11/06/2025

And that’s the start of what it’s going to be a very exciting @eular.org Congress! Open ceremony with @danielaletaha.bsky.social #EULAR2025

031

Reposted by Daniel Aletaha

SQUEEZE project @squeezeproject.bsky.social · 02/06/2025

🎙️ Mark the first of many SQUEEZE talks at #EULAR2025: "Add-on vs. Replacement csDMARDs post-MTX. A European analysis on csDMARD Treatment Choices." Presented by Nils Steinz from Leiden University Medical Center (LUMC) on June 12, at 10:50 am at room A2. #RA #DMARD #PrecisionMedicine

073

Daniel Aletaha @danielaletaha.bsky.social · 28/05/2025

🟣 Today, on International Day of Action for Women’s Health, we reaffirm: women’s health is central to rheumatology - from research to care. Let’s keep pushing forward. may28.org #WomensHealthMatters #Rheumatology #AutoimmuneDiseases #HealthEquity

may28.org

May 28 – International Day of Action for Women's Health

042

Daniel Aletaha @danielaletaha.bsky.social · 26/05/2025

I was interviewed by my team to share why EULAR 2025 in Barcelona will be exciting—and why you shouldn't miss it!📺 www.youtube.com/watch?v=rvf5... #EULAR2025

youtube.com

Prof. Daniel Aletaha on the upcoming EULAR 2025 Congress (#1)

YouTube video by Division of Rheumatology - MUW Vienna

010

Daniel Aletaha @danielaletaha.bsky.social · 22/05/2025

Can we prevent rheumatoid arthritis before it starts? Research on preclinical RA suggests early intervention could halt or delay the disease. Could prevention be the future of RA care? Read our latest editorial! 🔗 doi.org/10.1016/j.jb...

doi.org

Redirecting

000

Daniel Aletaha @danielaletaha.bsky.social · 15/05/2025

Last week was our first meetup with the Patient Research Partners involved in our IHI-funded AutoPiX project! We’re using AI to dig deeper into imaging data in rheumatic diseases care. Big thanks to everyone bringing their voice to the table! 💬🤝 #PatientInvolvement #Rheumatology #AI

011